Novo Nordisk faces US congressional grilling over price of weight loss drugs, FT reports-March 2024-www.financetom.com

Novo Nordisk faces US congressional grilling over price of weight loss drugs, FT reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Novo Nordisk faces US congressional grilling over price of weight loss drugs, FT reports

Sep 22, 2024 9:35 PM

Sept 23 (Reuters) - Novo Nordisk's chief

executive is preparing for a showdown next week with U.S.

Senator Bernie Sanders over the high price of blockbuster

diabetes and weight loss drugs, as Ozempic falls into the scope

of U.S. government price controls, the Financial Times reported

on Monday.

Previous page： Microsoft to invest 4.3 bln euros in Italy for AI infrastructure and cloud capacity Next page： Conagra Brands Fiscal First-Quarter Results Miss Street Views as Volumes Drop

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Microsoft to invest 4.3 bln euros in Italy for AI infrastructure and cloud capacity

Oct 2, 2024

MILAN, Oct 2 (Reuters) - Microsoft ( MSFT ) said in a statement on Wednesday it would invest 4.3 billion euros ($4.75 billion) over the next two years to strengthen artificial intelligence (AI) infrastructure and cloud capacity in Italy. The investment will be the company's largest in Italy to date, Microsoft ( MSFT ) added. ($1 = 0.9056 euros) ...

Conagra Brands Fiscal First-Quarter Results Miss Street Views as Volumes Drop

Oct 2, 2024

10:41 AM EDT, 10/02/2024 (MT Newswires) -- Conagra Brands' ( CAG ) fiscal first-quarter results fell year over year and missed Wall Street estimates, impacted by lower volumes and price headwinds. The packaged food maker reported adjusted earnings of $0.53 a share for the three months through Aug. 25, down from $0.66 the year before and below the Capital IQ-polled...

Charles River Laboratories International, Lundbeck Enter Deal for Logica Platform in Brain Disease Research

Oct 2, 2024

10:39 AM EDT, 10/02/2024 (MT Newswires) -- Charles River Laboratories International ( CRL ) said Wednesday that it agreed to a deal with H. Lundbeck to use Logica artificial intelligence-powered drug discovery platform for brain disease research. Financial terms of the agreement were not disclosed. Charles River shares were down 1.4% in recent trading. Price: 191.33, Change: -2.75, Percent Change:...

CERo Therapeutics Names Andrew Kucharchuk CFO, Kristen Pierce Chief Development Officer

Oct 2, 2024

10:42 AM EDT, 10/02/2024 (MT Newswires) -- CERo Therapeutics ( CERO ) said Wednesday that Andrew Kucharchuk has been named chief financial officer. Kucharchuk previously served as CFO of both Nukkelous and Chain Bridge I, the company said. CERo also named Kristen Pierce chief development officer. Pierce was previously vice president of translational medicine at Pionyr Therapeutics, CERo said. Price:...